-
But now there is the option of something stronger, known as a risk mitigation and evaluation strategy (REMS).
FORBES: What Arena Investors Should Worry About
-
The Risk Evaluation and Mitigation Strategy (REMS) targets extended-release (ER) and long-acting (LA) opioid drugs, including prescription medications containing oxycodone hydrochloride.
WHITEHOUSE: New Safety Measures for Opioid Medications
-
There were fears that FDA would saddle Merck with an onerous Risk Evaluation and Mitigation Strategy (REMS) program, which could reduce sales.
FORBES: Merck Wins Victory Over Skeptics With Hepatitis C Approval
-
Because vandetanib affects the electrical activity of the heart, potentially lethally, it is being sold under a Risk Evaluation and Mitigation Strategy (REMS).
FORBES: AstraZeneca's Victory Highlights Difficulty Of Cancer Drug Development
-
In order to get approved, Qnexa will probably need a risk evaluation and mitigation strategy (REMS), post-market studies, and warnings in its label, Carr says.
FORBES: Vivus Still Facing Rejection -- For Now
-
Because of the risk of liver toxicity, JUXTAPID is available only through a restricted program called the JUXTAPID Risk Evaluation and Mitigation Strategy (REMS) Program.
FORBES: FDA Approves Lomitapide For Homozygous Familial Hypercholesterolemia
-
The FDA approved Kynamro with a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use, including prescriber and pharmacy certification, and documentation of safe-use conditions, which requires a prescription authorization form for each new prescription.
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
-
Investors are expecting that there will not be a black box warning on the drug, and that any Risk Evaluation and Mitigation Strategy (REMS) plan these are special plans designed to limit who gets a medicine will be relatively lights.
FORBES: Human Genome Sciences' Benlysta Approved To Treat Lupus
-
The FDA will require that GSK develop a restricted access program for Avandia under a risk evaluation and mitigation strategy, or REMS. Under the REMS, Avandia will be available to new patients only if they are unable to achieve glucose control on other medications and are unable to take Actos (pioglitazone), the only other drug in this class.
FORBES: Avandia Saved By The Power of REMS